Operating Company Healthcare

Datavant

New York City, New York, United States

Datavant is a healthcare data collaboration platform that makes health data secure, accessible, and actionable—enabling secure movement and exchange of clinical and other health data across payers, providers, life sciences, and legal/insurance stakeholders using privacy-preserving technology.

Focus Areas
health data connectivity, privacy-preserving tokenization, health data linkage
Website
datavant.com

Tracked deals

7

7 tracked deals across 2019-2025.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Buyout

6 buyout · 1 divestiture

Datavant Acquisition Volume by Year

Last 5 years

Acquisition volume by year Annual acquisition counts for the last 5 years for Datavant. 1 2019 1 2021 1 2022 1 2024 3 2025

Supporting Data

Recent Transactions

  • Buyer
    Datavant
    Target
    DigitalOwl
    Type
    Buyout

    Datavant has completed the acquisition of DigitalOwl, an AI-driven medical data analysis platform, to enhance its capabilities for legal and insurance customers. The deal combines DigitalOwl's extraction, summarization and de-duplication technology with Datavant (and Ontellus') health record retrieval and claims intelligence to deliver an end-to-end health data collaboration platform.

  • Buyer
    Datavant
    Target
    Ontellus
    Seller
    Aquiline (Aquiline Capital Partners), Capstreet (The Capstreet Group)
    Industry
    Data & Analytics
    Location
    United States
    Type
    Buyout

    Datavant has signed an agreement to acquire Ontellus, a health records retrieval and claims intelligence provider, to build an integrated, digital-first platform for secure exchange of clinical and billing data. The combined organization is intended to reduce administrative burden for healthcare providers and improve how legal and insurance requesters obtain medical records and claimant timelines.

  • Buyer
    Datavant
    Target
    Aetion
    Location
    United States
    Type
    Buyout

    Datavant signed an agreement to acquire Aetion, a real-world evidence (RWE) platform used for healthcare and life sciences decision-making. The combined offering is intended to provide end-to-end RWE capabilities spanning data discovery, linkage, privacy, curation, and advanced analysis for regulators and industry stakeholders.

  • Buyer
    Datavant
    Target
    Apixio
    Seller
    Apixio
    Industry
    Data & Analytics

    Datavant has acquired Apixio's AI-powered Connected Care platform and value-based care solutions to expand its healthcare data and analytics capabilities. The deal brings Apixio's AI and value-based care tooling together with Datavant's health data network to accelerate actionable insights for payers and providers and support the shift to value-based care.

  • Buyer
    Datavant
    Target
    Convenet
    Location
    United Kingdom
    Type
    Buyout

    Datavant has acquired Convenet, a UK health-technology infrastructure company that built an NHS-approved API powering integration into the NHS Spine. The acquisition enables Datavant to expand privacy-preserving tokenization and data linkage capabilities into the United Kingdom, allowing clinical trial data to be linked to real-world NHS data and accelerating the company's international expansion.

  • Buyer
    Datavant, New Mountain Capital, Sixth Street, Goldman Sachs Asset Management, Roivant Sciences, Transformation Capital, Merck Global Health Innovation Fund, Labcorp, Cigna Ventures, Johnson & Johnson Innovation – JJDC, Inc., Flex Capital
    Target
    Ciox Health
    Industry
    Data & Analytics
    Type
    Buyout

    Datavant and Ciox Health signed a definitive agreement to merge in a transaction valued at $7.0 billion, creating a combined company to be named Datavant that will be the largest neutral health data ecosystem in the United States. The deal is supported by an investor group led by New Mountain Capital with significant new investment from Sixth Street and participation from Goldman Sachs Asset Management, Roivant Sciences and other strategic and financial investors; upon closing Pete McCabe will be CEO and Travis May will be President.

  • Buyer
    Datavant
    Target
    Health Data Link
    Industry
    Data & Analytics
    Type
    Buyout

    Datavant has acquired Health Data Link to integrate the latter's academic and government-focused data linkage capabilities into Datavant's open health data ecosystem. The deal brings Health Data Link's network of over 40 institutions into Datavant's ecosystem of 200+ institutions and moves several Health Data Link leaders into Datavant management roles to expand capabilities for research and health system customers.

Related Acquisition Pages

Selling a company? Get in front of buyers like Datavant

Turn tracked acquisition activity into an outreach-ready buyer list.